Digna to use Flamel's delivery tech in new products

Two drug-delivery technologies developed by the French company Flamel Technologies will play starring roles in a new deal the company has reached with the Spanish company Digna Biotech. Digna will use Flamel's Medusa and Micropump technologies in three initial Digna products. Report

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.